Skip to main content
Top
Published in: Multidisciplinary Respiratory Medicine 1/2014

Open Access 01-12-2014 | Review

The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*

Authors: Stefano Nardini, Isabella Annesi-Maesano, Mario Del Donno, Maurizio Delucchi, Germano Bettoncelli, Vincenzo Lamberti, Carlo Patera, Mario Polverino, Antonio Russo, Carlo Santoriello, Patrizio Soverina

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2014

Login to get access

Abstract

Respiratory diseases in Italy already now represent an emergency (they are the 3rd ranking cause of death in the world, and the 2nd if Lung cancer is included). In countries similar to our own, they result as the principal cause for a visit to the general practitioner (GP) and the second main cause after injury for recourse to Emergency Care. Their frequency is probably higher than estimated (given that respiratory diseases are currently underdiagnosed). The trend is towards a further increase due to epidemiologic and demographic factors (foremost amongst which are the widespread diffusion of cigarette smoking, the increasing mean age of the general population, immigration, and pollution). Within the more general problem of chronic disease care, chronic respiratory diseases (CRDs) constitute one of the four national priorities in that they represent an important burden for society in terms of mortality, invalidity, and direct healthcare costs. The strategy suggested by the World Health Organization (WHO) is an integrated approach consisting of three goals: inform about health, reduce risk exposure, improve patient care. The three goals are translated into practice in the three areas of prevention (1-primary, 2-secondary, 3-tertiary) as: 1) actions of primary (universal) prevention targeted at the general population with the aim to control the causes of disease, and actions of Predictive Medicine - again addressing the general population but aimed at measuring the individual’s risk for disease insurgence; 2) actions of early diagnosis targeted at groups or - more precisely - subgroups identified as at risk; 3) continuous improvement and integration of care and rehabilitation support - destined at the greatest possible number of patients, at all stages of disease severity. In Italy, COPD care is generally still inadequate. Existing guidelines, institutional and non-institutional, are inadequately implemented: the international guidelines are not always adaptable to the Italian context; the document of the Agency for Regional Healthcare Services (AGE.NA.S) is a more suited compendium for consultation, and the recent joint statement on integrated COPD management of the three major Italian scientific Associations in the respiratory area together with the contribution of a Society of General Medicine deals prevalently with some critical issues (appropriateness of diagnosis, pharmacological treatment, rehabilitation, continuing care); also the document “Care Continuity: Chronic Obstructive Pulmonary Disease (COPD)” of the Global Alliance against chronic Respiratory Diseases (GARD)-Italy does not treat in depth the issue of early diagnosis. The present document – produced by the AIMAR (Interdisciplinary Association for Research in Lung Disease) Task Force for early diagnosis of chronic respiratory disease based on the WHO/GARD model and on available evidence and expertise –after a general examination of the main epidemiologic aspects, proposes to integrate the above-mentioned existing documents. In particular: a) it formally indicates on the basis of the available evidence the modalities and the instruments necessary for carrying out secondary prevention at the primary care level (a pro-active,‘case-finding’approach; assessment of the individual’s level of risk of COPD; use of short questionnaires for an initial screening based on symptoms; use of simple spirometry for the second level of screening); b) it identifies possible ways of including these activities within primary care practice; c) it places early diagnosis within the “systemic”, consequential management of chronic respiratory diseases, which will be briefly described with the aid of schemes taken from the Italian and international reference documents.
Appendix
Available only for authorised users
Literature
4.
go back to reference Improve healthcare by reducing unnecessary emergency admissions. n° 2006/0104, 20 Marzo 2006 Improve healthcare by reducing unnecessary emergency admissions. n° 2006/0104, 20 Marzo 2006
5.
go back to reference Regione Veneto:Allegato “A” a DGR n^ 68/18, giugno. 2013 Regione Veneto:Allegato “A” a DGR n^ 68/18, giugno. 2013
6.
go back to reference Schiarire l'aria: uno studio nazionale sulla bronco pneumopatia cronica ostruttiva. Multidiscip Resp Med. 2007, 2 (1): 19-22. Schiarire l'aria: uno studio nazionale sulla bronco pneumopatia cronica ostruttiva. Multidiscip Resp Med. 2007, 2 (1): 19-22.
8.
go back to reference De Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Sunyer J, Svanes C, Wjst M, Burney P, European Community Respiratory Health Survey (ECRHS): Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011, 183: 891-897. 10.1164/rccm.201007-1125OC.CrossRefPubMed De Marco R, Accordini S, Marcon A, Cerveri I, Antó JM, Gislason T, Heinrich J, Janson C, Jarvis D, Kuenzli N, Leynaert B, Sunyer J, Svanes C, Wjst M, Burney P, European Community Respiratory Health Survey (ECRHS): Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. 2011, 183: 891-897. 10.1164/rccm.201007-1125OC.CrossRefPubMed
9.
go back to reference Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS) Broncopneumopatia Cronica Ostruttiva - Linee guida nazionali di riferimento per la prevenzione e la terapia Roma. 2011 Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS) Broncopneumopatia Cronica Ostruttiva - Linee guida nazionali di riferimento per la prevenzione e la terapia Roma. 2011
10.
go back to reference Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemie MJ: Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of populationestimates with general practice databases and National survey. BMC Public Health. 2013, 13: 15-10.1186/1471-2458-13-15.PubMedCentralCrossRefPubMed Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemie MJ: Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of populationestimates with general practice databases and National survey. BMC Public Health. 2013, 13: 15-10.1186/1471-2458-13-15.PubMedCentralCrossRefPubMed
11.
go back to reference Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C: Prevalence of airways obstruction in a general population. European Respiratory Society vs American Thoracic Society definition. Chest. 2000, 117 (5Suppl2): 339S-345S.CrossRefPubMed Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C: Prevalence of airways obstruction in a general population. European Respiratory Society vs American Thoracic Society definition. Chest. 2000, 117 (5Suppl2): 339S-345S.CrossRefPubMed
13.
go back to reference Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B: Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005, 72: 471-479. 10.1159/000087670.CrossRefPubMed Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B: Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005, 72: 471-479. 10.1159/000087670.CrossRefPubMed
14.
go back to reference Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson LG, Lundbäck B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung disease in Northern Sweden Studies. Respir Med. 2006, 100: 264-272. 10.1016/j.rmed.2005.04.029.CrossRefPubMed Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson LG, Lundbäck B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the Obstructive Lung disease in Northern Sweden Studies. Respir Med. 2006, 100: 264-272. 10.1016/j.rmed.2005.04.029.CrossRefPubMed
15.
go back to reference Dekhuijzen PN: The Confronting COPD International Survey: patients hardly know they have COPD. Eur Respir J. 2002, 20: 793-794. 10.1183/09031936.02.00404402.CrossRefPubMed Dekhuijzen PN: The Confronting COPD International Survey: patients hardly know they have COPD. Eur Respir J. 2002, 20: 793-794. 10.1183/09031936.02.00404402.CrossRefPubMed
16.
go back to reference Beniwal S, Sharma BB, Singh V: What we can say: disease illiteracy. J Assoc Physicians India. 2011, 59: 360-364.PubMed Beniwal S, Sharma BB, Singh V: What we can say: disease illiteracy. J Assoc Physicians India. 2011, 59: 360-364.PubMed
17.
go back to reference Murray CJ, Lopez AD: Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of disease Study. Lancet. 1997, 349: 1347-1352. 10.1016/S0140-6736(96)07494-6.CrossRefPubMed Murray CJ, Lopez AD: Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of disease Study. Lancet. 1997, 349: 1347-1352. 10.1016/S0140-6736(96)07494-6.CrossRefPubMed
18.
go back to reference Shahab L, Jarvis MJ, Britton J, West R: Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006, 61: 1043-1047. 10.1136/thx.2006.064410.PubMedCentralCrossRefPubMed Shahab L, Jarvis MJ, Britton J, West R: Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006, 61: 1043-1047. 10.1136/thx.2006.064410.PubMedCentralCrossRefPubMed
19.
go back to reference Nardini S, De Benedetto F, Sanguinetti CM, Donner CF, per AIMAR (Associazione Scientifica Interdisciplinare per lo studio delle malattie Respiratorie): Il Progetto “SOS Respiro” di AIMAR. I risultati del primo progetto Italiano globale su COPD ed asma. Multidiscip Resp Med. 2007, 2 (4): 16-23. Nardini S, De Benedetto F, Sanguinetti CM, Donner CF, per AIMAR (Associazione Scientifica Interdisciplinare per lo studio delle malattie Respiratorie): Il Progetto “SOS Respiro” di AIMAR. I risultati del primo progetto Italiano globale su COPD ed asma. Multidiscip Resp Med. 2007, 2 (4): 16-23.
20.
go back to reference Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C: The prevalence of chronic obstructive pulmonary of disease in Uppsala, Sweden--the Burden of Obstructive Lung disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012, 6 (2): 120-127. 10.1111/j.1752-699X.2011.00257.x.CrossRefPubMed Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C: The prevalence of chronic obstructive pulmonary of disease in Uppsala, Sweden--the Burden of Obstructive Lung disease (BOLD) study: cross-sectional population-based study. Clin Respir J. 2012, 6 (2): 120-127. 10.1111/j.1752-699X.2011.00257.x.CrossRefPubMed
21.
go back to reference Rycroft CE, Heyes A, Lance L, Becker K: Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012, 7: 457-494.PubMedCentralCrossRefPubMed Rycroft CE, Heyes A, Lance L, Becker K: Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012, 7: 457-494.PubMedCentralCrossRefPubMed
22.
go back to reference Halbert RJ, Isonaka S, George D, Iqbal A: Interpreting COPD prevalence estimates: what is the true burden of disease?. Chest. 2003, 123 (5): 1684-1692. 10.1378/chest.123.5.1684.CrossRefPubMed Halbert RJ, Isonaka S, George D, Iqbal A: Interpreting COPD prevalence estimates: what is the true burden of disease?. Chest. 2003, 123 (5): 1684-1692. 10.1378/chest.123.5.1684.CrossRefPubMed
23.
go back to reference Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28 (3): 523-532. 10.1183/09031936.06.00124605.CrossRefPubMed Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28 (3): 523-532. 10.1183/09031936.06.00124605.CrossRefPubMed
24.
go back to reference Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandström T, Lundbäck B: Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest. 2006, 129 (4): 879-885. 10.1378/chest.129.4.879.CrossRefPubMed Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandström T, Lundbäck B: Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest. 2006, 129 (4): 879-885. 10.1378/chest.129.4.879.CrossRefPubMed
26.
go back to reference Lusuardi M, Orlandini D, Han MK, Martinez FJ: Underutilization of spirometry for the diagnosis of COPD. Chest. 2008, 133: 313-314. 10.1378/chest.07-2172.CrossRefPubMed Lusuardi M, Orlandini D, Han MK, Martinez FJ: Underutilization of spirometry for the diagnosis of COPD. Chest. 2008, 133: 313-314. 10.1378/chest.07-2172.CrossRefPubMed
27.
go back to reference Lusuardi M, Blasi F, Terzano C, Cricelli C, Crispino N, Comarella L, De Benedetto F, Sanguinetti CM, Allegra L, Donner CF: Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation - The Italian SOS Study (Stratification Observational Study). Monaldi Arch Chest Dis. 2009, 71: 4,153-160 Lusuardi M, Blasi F, Terzano C, Cricelli C, Crispino N, Comarella L, De Benedetto F, Sanguinetti CM, Allegra L, Donner CF: Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation - The Italian SOS Study (Stratification Observational Study). Monaldi Arch Chest Dis. 2009, 71: 4,153-160
28.
go back to reference Piperno D, Huchon G, Pribil C, Boucot I, Similowski T: The burden of COPD in France: results from the Confronting COPD survey. Respir Med. 2003, 97 (Suppl C): S33-S42.CrossRefPubMed Piperno D, Huchon G, Pribil C, Boucot I, Similowski T: The burden of COPD in France: results from the Confronting COPD survey. Respir Med. 2003, 97 (Suppl C): S33-S42.CrossRefPubMed
45.
go back to reference Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, Alvarez-Sala JL: Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006, 100 (11): 1973-1980. 10.1016/j.rmed.2006.02.024.CrossRefPubMed Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, Alvarez-Sala JL: Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med. 2006, 100 (11): 1973-1980. 10.1016/j.rmed.2006.02.024.CrossRefPubMed
46.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Ofsease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176 (6): 532-555. 10.1164/rccm.200703-456SO.CrossRefPubMed Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Ofsease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176 (6): 532-555. 10.1164/rccm.200703-456SO.CrossRefPubMed
47.
go back to reference Van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ: Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002, 324: 1370-10.1136/bmj.324.7350.1370.PubMedCentralCrossRefPubMed Van Schayck CP, Loozen JMC, Wagena E, Akkermans RP, Wesseling GJ: Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ. 2002, 324: 1370-10.1136/bmj.324.7350.1370.PubMedCentralCrossRefPubMed
48.
go back to reference Tønnesen P: Smoking cessation and COPD. Eur Respir Rev. 2013, 22 (127): 37-43. 10.1183/09059180.00007212.CrossRefPubMed Tønnesen P: Smoking cessation and COPD. Eur Respir Rev. 2013, 22 (127): 37-43. 10.1183/09059180.00007212.CrossRefPubMed
49.
go back to reference Alderson SL, Foy R, Glidewell L, McLintock K, House A: How patients understand depression associated with chronic physical disease – a systematic review. BMC Fam Pract. 2012, 13: 41-10.1186/1471-2296-13-41.PubMedCentralCrossRefPubMed Alderson SL, Foy R, Glidewell L, McLintock K, House A: How patients understand depression associated with chronic physical disease – a systematic review. BMC Fam Pract. 2012, 13: 41-10.1186/1471-2296-13-41.PubMedCentralCrossRefPubMed
50.
go back to reference Petty TL: Definitions, causes, course, and prognosis of chronic obstructive pulmonary disease. Respir Care Clin N Am. 1998, 4: 345-358.PubMed Petty TL: Definitions, causes, course, and prognosis of chronic obstructive pulmonary disease. Respir Care Clin N Am. 1998, 4: 345-358.PubMed
51.
go back to reference Rudolf M: The reality of drug use in COPD: the European perspective. Chest. 2000, 117 (2 suppl): 29S-32S.CrossRefPubMed Rudolf M: The reality of drug use in COPD: the European perspective. Chest. 2000, 117 (2 suppl): 29S-32S.CrossRefPubMed
52.
go back to reference Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D: Development of a population-based screening questionnaire for COPD. COPD. 2005, 2 (2): 225-232. 10.1081/COPD-57594.CrossRefPubMed Calverley PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D: Development of a population-based screening questionnaire for COPD. COPD. 2005, 2 (2): 225-232. 10.1081/COPD-57594.CrossRefPubMed
53.
go back to reference van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D: Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology. 2005, 10 (3): 323-333. 10.1111/j.1440-1843.2005.00720.x.CrossRefPubMed van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D: Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology. 2005, 10 (3): 323-333. 10.1111/j.1440-1843.2005.00720.x.CrossRefPubMed
54.
go back to reference Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Price D, Halbert RJ: Questions for COPD diagnostic screening in a primary care setting. Respir Med. 2005, 99 (10): 1311-1318. 10.1016/j.rmed.2005.02.037.CrossRefPubMed Freeman D, Nordyke RJ, Isonaka S, Nonikov DV, Maroni JM, Price D, Halbert RJ: Questions for COPD diagnostic screening in a primary care setting. Respir Med. 2005, 99 (10): 1311-1318. 10.1016/j.rmed.2005.02.037.CrossRefPubMed
55.
go back to reference Mapel DW, Frost FJ, Hurley JS, Petersen H, Roberts M, Marton JP, Shah H: An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm. 2006, 12 (6): 457-465.PubMed Mapel DW, Frost FJ, Hurley JS, Petersen H, Roberts M, Marton JP, Shah H: An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm. 2006, 12 (6): 457-465.PubMed
56.
go back to reference Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, COPD Questionnaire Study Group: Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006, 129 (6): 1531-1539. 10.1378/chest.129.6.1531.CrossRefPubMed Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ, COPD Questionnaire Study Group: Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006, 129 (6): 1531-1539. 10.1378/chest.129.6.1531.CrossRefPubMed
57.
go back to reference Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ, Mannino DM, Thomashow BM: Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012, 142 (2): 358-366.CrossRefPubMed Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ, Mannino DM, Thomashow BM: Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012, 142 (2): 358-366.CrossRefPubMed
58.
go back to reference Hegewald MJ, Lefor MJ, Jensen RL, Crapo RO, Kritchevsky SB, Haggerty CL, Bauer DC, Satterfield S, Harris T: Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population. Chest. 2007, 131: 1494-1499. 10.1378/chest.06-2707.CrossRefPubMed Hegewald MJ, Lefor MJ, Jensen RL, Crapo RO, Kritchevsky SB, Haggerty CL, Bauer DC, Satterfield S, Harris T: Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population. Chest. 2007, 131: 1494-1499. 10.1378/chest.06-2707.CrossRefPubMed
61.
go back to reference Dirven JA, Tange HJ, Muris JW, van Haaren KM, Vink G, van Schayck OC: Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim Care Respir J. 2013, 22 (3): 331-337. 10.4104/pcrj.2013.00070.CrossRefPubMed Dirven JA, Tange HJ, Muris JW, van Haaren KM, Vink G, van Schayck OC: Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim Care Respir J. 2013, 22 (3): 331-337. 10.4104/pcrj.2013.00070.CrossRefPubMed
62.
go back to reference Stratelis G, Jakobsson P, Molstad S, Zetterstrom O: Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 2004, 54 (500): 201-206.PubMedCentralPubMed Stratelis G, Jakobsson P, Molstad S, Zetterstrom O: Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 2004, 54 (500): 201-206.PubMedCentralPubMed
63.
go back to reference Zuccaro P, Pichini S, Mortali C, Pacifici R, Viegi G, Baldacci S, Angino A, Martini F, Borbotti M, Scognamiglio A, Simoni M, Silvi P, DiPede F, Carrozzi L, Porta D, Simonato L, Crispo A, Merletti F, Forastiere F: Fumo e patologie respiratorie: le carte del rischio per COPD e tumore al polmone. Multidiscip Resp Med. 2007, 2: 14-21. Zuccaro P, Pichini S, Mortali C, Pacifici R, Viegi G, Baldacci S, Angino A, Martini F, Borbotti M, Scognamiglio A, Simoni M, Silvi P, DiPede F, Carrozzi L, Porta D, Simonato L, Crispo A, Merletti F, Forastiere F: Fumo e patologie respiratorie: le carte del rischio per COPD e tumore al polmone. Multidiscip Resp Med. 2007, 2: 14-21.
66.
go back to reference Ferro A, Cinquetti S, Moro A, Siddu A, Trimarchi A, Penon MG, Pavan PP, Camillotto R, Rossetto L, Volpe V, Zevrain S, Brusaferro S: Prevenire le patologie cardiovascolari attraverso un modello di valutazione proattiva del rischio (screening) applicabile ad ampie fasce di popolazione. Risultati della prima fase del progetto. Epidemiologia e Prevenzione. 2013, in press Ferro A, Cinquetti S, Moro A, Siddu A, Trimarchi A, Penon MG, Pavan PP, Camillotto R, Rossetto L, Volpe V, Zevrain S, Brusaferro S: Prevenire le patologie cardiovascolari attraverso un modello di valutazione proattiva del rischio (screening) applicabile ad ampie fasce di popolazione. Risultati della prima fase del progetto. Epidemiologia e Prevenzione. 2013, in press
67.
go back to reference Cawley MJ, Moon J, Reinhold J, Willey VJ, Warning Ii WJ: Spirometry: tool for pharmacy practitioners to expand direct patient care services. J Am Pharm Assoc (2003). 2013, 53 (3): 307-315. 10.1331/JAPhA.2013.12134.CrossRef Cawley MJ, Moon J, Reinhold J, Willey VJ, Warning Ii WJ: Spirometry: tool for pharmacy practitioners to expand direct patient care services. J Am Pharm Assoc (2003). 2013, 53 (3): 307-315. 10.1331/JAPhA.2013.12134.CrossRef
68.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.CrossRefPubMed
69.
go back to reference Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W: FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005, 127: 1560-1564. 10.1378/chest.127.5.1560.CrossRefPubMed Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W: FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005, 127: 1560-1564. 10.1378/chest.127.5.1560.CrossRefPubMed
70.
go back to reference Korhonen H, Remes ST, Kannisto S, Korppi M: Hand-held turbine spirometer: agreement with the conventional spirometer at baseline and after exercise. Pediatr Allergy Immunol. 2005, 16 (3): 254-257. 10.1111/j.1399-3038.2005.00252.x.CrossRefPubMed Korhonen H, Remes ST, Kannisto S, Korppi M: Hand-held turbine spirometer: agreement with the conventional spirometer at baseline and after exercise. Pediatr Allergy Immunol. 2005, 16 (3): 254-257. 10.1111/j.1399-3038.2005.00252.x.CrossRefPubMed
71.
go back to reference Schermer TR, Verweij EH, Cretier R, Pellegrino A, Crockett AJ, Poels PJ: Accuracy and precision of desktop spirometers in general practices. Respiration. 2012, 83 (4): 344-352. 10.1159/000334320.CrossRefPubMed Schermer TR, Verweij EH, Cretier R, Pellegrino A, Crockett AJ, Poels PJ: Accuracy and precision of desktop spirometers in general practices. Respiration. 2012, 83 (4): 344-352. 10.1159/000334320.CrossRefPubMed
72.
go back to reference Ofrksen A, Madsen F, Pedersen OF, Vedel AM, Kok-Jensen A: Long term performance of a hand held spirometer. Thorax. 1996, 51: 973-976. 10.1136/thx.51.10.973.CrossRef Ofrksen A, Madsen F, Pedersen OF, Vedel AM, Kok-Jensen A: Long term performance of a hand held spirometer. Thorax. 1996, 51: 973-976. 10.1136/thx.51.10.973.CrossRef
73.
go back to reference Malmberg LP, Hedman J, Sovijärvi AR: Accuracy and repeatability of a pocket turbine spirometer: comparison with a rolling seal flow-volume spirometer. Clin Physiol. 1993, 13 (1): 89-98. 10.1111/j.1475-097X.1993.tb00320.x.CrossRefPubMed Malmberg LP, Hedman J, Sovijärvi AR: Accuracy and repeatability of a pocket turbine spirometer: comparison with a rolling seal flow-volume spirometer. Clin Physiol. 1993, 13 (1): 89-98. 10.1111/j.1475-097X.1993.tb00320.x.CrossRefPubMed
74.
go back to reference Enright PL: How to make sure your Spirometry Tests are of good quality. Respir Care. 2003, 48 (8): 773-776.PubMed Enright PL: How to make sure your Spirometry Tests are of good quality. Respir Care. 2003, 48 (8): 773-776.PubMed
75.
go back to reference Dowson LJ, Yeung A, Allen MB: General practice spirometry in North Staffordshire. Monaldi Arch Chest Dis. 1999, 54 (2): 186-188.PubMed Dowson LJ, Yeung A, Allen MB: General practice spirometry in North Staffordshire. Monaldi Arch Chest Dis. 1999, 54 (2): 186-188.PubMed
76.
go back to reference Bracci M, Strafella E, Croce N, Staffolani S, Carducci A, Verani M, Valentino M, Santarelli L: Risk of bacterial cross infection associated with inspiration through flow-based spirometers. Am J Infect Control. 2011, 39 (1): 50-55. 10.1016/j.ajic.2010.04.215.CrossRefPubMed Bracci M, Strafella E, Croce N, Staffolani S, Carducci A, Verani M, Valentino M, Santarelli L: Risk of bacterial cross infection associated with inspiration through flow-based spirometers. Am J Infect Control. 2011, 39 (1): 50-55. 10.1016/j.ajic.2010.04.215.CrossRefPubMed
77.
go back to reference Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, Donner CF: A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006, 129 (4): 844-852. 10.1378/chest.129.4.844.CrossRefPubMed Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, Donner CF: A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest. 2006, 129 (4): 844-852. 10.1378/chest.129.4.844.CrossRefPubMed
78.
go back to reference Enright P: The use and abuse of office spirometry. Prim Care Respir J. 2008, 17 (4): 238-242. 10.3132/pcrj.2008.00065.CrossRefPubMed Enright P: The use and abuse of office spirometry. Prim Care Respir J. 2008, 17 (4): 238-242. 10.3132/pcrj.2008.00065.CrossRefPubMed
79.
go back to reference Enright P: Provide GPs with spirometry not spirometers. Thorax. 2008, 63 (5): 387-388. 10.1136/thx.2007.092916.CrossRefPubMed Enright P: Provide GPs with spirometry not spirometers. Thorax. 2008, 63 (5): 387-388. 10.1136/thx.2007.092916.CrossRefPubMed
80.
go back to reference Nardini S, Cicchitto G, De Benedetto F, Donner CF, Polverino M, Sanguinetti CM, Visconti A: Audit sull’ appropriatezza nell’assistenza integrata della BPCO. Il progetto “ALT-BPCO”. Multidiscip Resp Med. 2012, 7 (5-6): I-XII. Nardini S, Cicchitto G, De Benedetto F, Donner CF, Polverino M, Sanguinetti CM, Visconti A: Audit sull’ appropriatezza nell’assistenza integrata della BPCO. Il progetto “ALT-BPCO”. Multidiscip Resp Med. 2012, 7 (5-6): I-XII.
81.
go back to reference Culver BH: How Should the Lower Limit of the Normal Range Be Defined?. Respir Care. 2012, 57: 136-145. 10.4187/respcare.01427.CrossRefPubMed Culver BH: How Should the Lower Limit of the Normal Range Be Defined?. Respir Care. 2012, 57: 136-145. 10.4187/respcare.01427.CrossRefPubMed
82.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968. 10.1183/09031936.05.00035205.CrossRefPubMed Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968. 10.1183/09031936.05.00035205.CrossRefPubMed
84.
go back to reference Celli BR, Halbert RJ, Isonaka S, Schau B: Population impact of different definitions of airway obstruction. Eur Respir J. 2003, 22 (2): 268-273. 10.1183/09031936.03.00075102.CrossRefPubMed Celli BR, Halbert RJ, Isonaka S, Schau B: Population impact of different definitions of airway obstruction. Eur Respir J. 2003, 22 (2): 268-273. 10.1183/09031936.03.00075102.CrossRefPubMed
85.
go back to reference Mohamed Hoesein FA, Zanen P, Lammers JW: Lower limit of normal or FEV1/FVC < 0.70 in diagnosisng COPD: an evidence-based review. Respir Med. 2011, 105 (6): 907-915. 10.1016/j.rmed.2011.01.008.CrossRefPubMed Mohamed Hoesein FA, Zanen P, Lammers JW: Lower limit of normal or FEV1/FVC < 0.70 in diagnosisng COPD: an evidence-based review. Respir Med. 2011, 105 (6): 907-915. 10.1016/j.rmed.2011.01.008.CrossRefPubMed
86.
go back to reference National Institute for Clinical Excellence (NICE) Clinical Guideline Centre: Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. Update Guideline. 2011, 72-74. National Institute for Clinical Excellence (NICE) Clinical Guideline Centre: Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. Update Guideline. 2011, 72-74.
87.
go back to reference Nishimura K, Izumu T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002, 121: 1434-1440. 10.1378/chest.121.5.1434.CrossRefPubMed Nishimura K, Izumu T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002, 121: 1434-1440. 10.1378/chest.121.5.1434.CrossRefPubMed
88.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Méndez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.CrossRefPubMed Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Méndez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.CrossRefPubMed
89.
go back to reference Anzueto A, Leimer I, Kesten S: Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J COPD. 2009, 4: 245-251. Anzueto A, Leimer I, Kesten S: Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J COPD. 2009, 4: 245-251.
90.
go back to reference Sullivan SD, Buist AS, Weiss K: Health outcome assessment and economic evaluation in COPD: challenges and opportunities. Eur Respir J. 2003, 21 (suppl.41): 1s-3s.CrossRef Sullivan SD, Buist AS, Weiss K: Health outcome assessment and economic evaluation in COPD: challenges and opportunities. Eur Respir J. 2003, 21 (suppl.41): 1s-3s.CrossRef
91.
go back to reference Effing T, Monninkhof EEM, van der Valk PD, van der Palen J, van Herwaarden CL, Partridge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 4: CD002990-doi:10.1002/14651858.CD002990.pub2PubMed Effing T, Monninkhof EEM, van der Valk PD, van der Palen J, van Herwaarden CL, Partridge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, 4: CD002990-doi:10.1002/14651858.CD002990.pub2PubMed
92.
go back to reference Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE: Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007, 167 (6): 551-561. 10.1001/archinte.167.6.551.CrossRefPubMed Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE: Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007, 167 (6): 551-561. 10.1001/archinte.167.6.551.CrossRefPubMed
93.
go back to reference Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE: Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010, 182 (7): 890-896. 10.1164/rccm.200910-1579OC.CrossRefPubMed Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE: Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010, 182 (7): 890-896. 10.1164/rccm.200910-1579OC.CrossRefPubMed
94.
go back to reference Walters JAE, Turnock AC, Walters EH, Wood-Baker R: Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010, 5: CD005074-doi:10.1002/14651858.CD005074.pub3PubMed Walters JAE, Turnock AC, Walters EH, Wood-Baker R: Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010, 5: CD005074-doi:10.1002/14651858.CD005074.pub3PubMed
95.
go back to reference McLean S, Nurmatov U, Liu JLY, Pagliari C, Car J, Sheikh A: Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011, 7: CD007718-doi:10.1002/14651858.CD007718.pub2PubMed McLean S, Nurmatov U, Liu JLY, Pagliari C, Car J, Sheikh A: Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011, 7: CD007718-doi:10.1002/14651858.CD007718.pub2PubMed
96.
go back to reference Koff PB, Jones RH, Cashman JM, Voelkel NF, Vanofvier RW: Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009, 33 (5): 1031-1038. 10.1183/09031936.00063108.CrossRefPubMed Koff PB, Jones RH, Cashman JM, Voelkel NF, Vanofvier RW: Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009, 33 (5): 1031-1038. 10.1183/09031936.00063108.CrossRefPubMed
97.
go back to reference Clark NM, Dodge JA, Partridge MR, Martinez FJ: Focusing on outcomes: making the most of COPD interventions. Int J Chron Obstruct Pulmon Dis. 2009, 4: 61-77.PubMedCentralPubMed Clark NM, Dodge JA, Partridge MR, Martinez FJ: Focusing on outcomes: making the most of COPD interventions. Int J Chron Obstruct Pulmon Dis. 2009, 4: 61-77.PubMedCentralPubMed
99.
go back to reference Yawn BP, Colice GL, Hodder R: Practical aspects of inhaler use in the management of chronic obstructive pulmonary Disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012, 7: 495-502.PubMedCentralCrossRefPubMed Yawn BP, Colice GL, Hodder R: Practical aspects of inhaler use in the management of chronic obstructive pulmonary Disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012, 7: 495-502.PubMedCentralCrossRefPubMed
100.
go back to reference Tønnesen P, Carrozzi L, Fagerstroem KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007, 29: 390-417.CrossRefPubMed Tønnesen P, Carrozzi L, Fagerstroem KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R: Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007, 29: 390-417.CrossRefPubMed
101.
go back to reference Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J: Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest. 2003, 123 (6): 1916-1923. 10.1378/chest.123.6.1916.CrossRefPubMed Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J: Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest. 2003, 123 (6): 1916-1923. 10.1378/chest.123.6.1916.CrossRefPubMed
102.
go back to reference Stratelis G, Mölstad S, Jakobsson P, Zetterström O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006, 24 (3): 133-139. 10.1080/02813430600819751.CrossRefPubMed Stratelis G, Mölstad S, Jakobsson P, Zetterström O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006, 24 (3): 133-139. 10.1080/02813430600819751.CrossRefPubMed
103.
go back to reference Fiore M, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME, Murray EW, Bennett G, Heishman S, Husten C, Morgan G, Williams C, Christiansen BA, Piper ME, Hasselblad V, Fraser D, Theobald W, Connell M, Leitzke C: Treating tobacco use and dependence: 2008 update. U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008, 53: 1217-1222. Fiore M, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME, Murray EW, Bennett G, Heishman S, Husten C, Morgan G, Williams C, Christiansen BA, Piper ME, Hasselblad V, Fraser D, Theobald W, Connell M, Leitzke C: Treating tobacco use and dependence: 2008 update. U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008, 53: 1217-1222.
105.
106.
go back to reference Lindson-Hawley N, Aveyard P, Hughes JR: Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012, 11: CD008033-PubMed Lindson-Hawley N, Aveyard P, Hughes JR: Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012, 11: CD008033-PubMed
107.
go back to reference Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P: Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009, 338: b1024-10.1136/bmj.b1024.PubMedCentralCrossRefPubMed Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P: Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009, 338: b1024-10.1136/bmj.b1024.PubMedCentralCrossRefPubMed
108.
go back to reference Lee PN: The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardio-vascular disease and FEV1 - a review. Regul Toxicol Pharmacol. 2013, 67: 372-381. 10.1016/j.yrtph.2013.08.016.CrossRefPubMed Lee PN: The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardio-vascular disease and FEV1 - a review. Regul Toxicol Pharmacol. 2013, 67: 372-381. 10.1016/j.yrtph.2013.08.016.CrossRefPubMed
109.
go back to reference Nardini S, Pacifici R: E-cigarettes, smokers and health policies. Monaldi Arch Chest Dis. 2013, 79 (1): 6-7.PubMed Nardini S, Pacifici R: E-cigarettes, smokers and health policies. Monaldi Arch Chest Dis. 2013, 79 (1): 6-7.PubMed
110.
go back to reference Bateman E, Vogelmeier C, Chen H, Banerji D: Comparison of COPD exacerbations with once-daily QVA149 versus twice-daily Salmeterol/Fluticasone Combination: The ILLUMINATE Study. Chest. 2014, 145 (3 Suppl): 409A-doi:10.1378/chest.1824338CrossRef Bateman E, Vogelmeier C, Chen H, Banerji D: Comparison of COPD exacerbations with once-daily QVA149 versus twice-daily Salmeterol/Fluticasone Combination: The ILLUMINATE Study. Chest. 2014, 145 (3 Suppl): 409A-doi:10.1378/chest.1824338CrossRef
111.
go back to reference Wedzicha J, Ficker J, Fowlertaylor A, D'Andrea P, Arrasate C, Chen H, Banerji D: Once-Daily QVA149 reduces exacerbations and improves health status in comparison with glycopyrronium and tiotropium in patients with severe-to-very severe COPD: The SPARK Study. Chest. 2014, 145 (3 Suppl): 427A-doi:10.1378/chest.1824414CrossRef Wedzicha J, Ficker J, Fowlertaylor A, D'Andrea P, Arrasate C, Chen H, Banerji D: Once-Daily QVA149 reduces exacerbations and improves health status in comparison with glycopyrronium and tiotropium in patients with severe-to-very severe COPD: The SPARK Study. Chest. 2014, 145 (3 Suppl): 427A-doi:10.1378/chest.1824414CrossRef
112.
go back to reference Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004, 200: 689-695. 10.1084/jem.20040416.PubMedCentralCrossRefPubMed Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004, 200: 689-695. 10.1084/jem.20040416.PubMedCentralCrossRefPubMed
113.
go back to reference Ancochea J, Gómez García T, de Miguel DJ: Hacia un tratamiento individualizado e integrado del paciente con EPOC. Arch Bronconeumol. 2010, 46 (Suppl 10): 14-18.CrossRefPubMed Ancochea J, Gómez García T, de Miguel DJ: Hacia un tratamiento individualizado e integrado del paciente con EPOC. Arch Bronconeumol. 2010, 46 (Suppl 10): 14-18.CrossRefPubMed
114.
go back to reference Collins PF, Stratton RJ, Elia M: Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012, 95: 1385-1395. 10.3945/ajcn.111.023499.CrossRefPubMed Collins PF, Stratton RJ, Elia M: Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012, 95: 1385-1395. 10.3945/ajcn.111.023499.CrossRefPubMed
116.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T: ATS/ERS Pulmonary Rehabilitation Writing Committee: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006, 173 (12): 1390-1413. 10.1164/rccm.200508-1211ST.CrossRefPubMed Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T: ATS/ERS Pulmonary Rehabilitation Writing Committee: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006, 173 (12): 1390-1413. 10.1164/rccm.200508-1211ST.CrossRefPubMed
117.
go back to reference Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C: Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007, 131 (suppl 5): 4S-42S.CrossRefPubMed Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C: Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007, 131 (suppl 5): 4S-42S.CrossRefPubMed
118.
go back to reference Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011, 10: CD005305-PubMed Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J: Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011, 10: CD005305-PubMed
121.
go back to reference McCurdy BR: Hospital-at-home programs for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012, 12: 1-65. McCurdy BR: Hospital-at-home programs for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012, 12: 1-65.
123.
go back to reference Macintyre NR: Chronic critical illness: the growing challenge to health care. Respir Care. 2012, 57 (6): 1021-1027. 10.4187/respcare.01768.CrossRefPubMed Macintyre NR: Chronic critical illness: the growing challenge to health care. Respir Care. 2012, 57 (6): 1021-1027. 10.4187/respcare.01768.CrossRefPubMed
124.
go back to reference American Thoracic Society Documents Statement on Home Care for Patients with Respiratory Disorders. Am J Respir Crit Care Med. 2005, 171: 1443-1464. American Thoracic Society Documents Statement on Home Care for Patients with Respiratory Disorders. Am J Respir Crit Care Med. 2005, 171: 1443-1464.
126.
go back to reference Legge n°38 del. 2010, “Disposizioni per garantire l’accesso alle cure palliative e alla terapia del dolore”- Intesa Stato-Regioni del 25 luglio 2012 “Requisiti minimi organizzativi per l’accreditamento delle reti di cure palliative e di terapia del dolore Legge n°38 del. 2010, “Disposizioni per garantire l’accesso alle cure palliative e alla terapia del dolore”- Intesa Stato-Regioni del 25 luglio 2012 “Requisiti minimi organizzativi per l’accreditamento delle reti di cure palliative e di terapia del dolore
127.
go back to reference Lanken PN, Terry PB, DeLisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, Levy M, Mularski RA, Osborne ML, Prendergast TJ, Rocker G, Sibbald WJ†, Wilfond B, Yankaskas JR, on behalf of the ATS End-of-Life Care Task Force: An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses. Am J Respir Crit Care Med. 2008, 177: 912-927. 10.1164/rccm.200605-587ST.CrossRefPubMed Lanken PN, Terry PB, DeLisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, Levy M, Mularski RA, Osborne ML, Prendergast TJ, Rocker G, Sibbald WJ†, Wilfond B, Yankaskas JR, on behalf of the ATS End-of-Life Care Task Force: An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical Illnesses. Am J Respir Crit Care Med. 2008, 177: 912-927. 10.1164/rccm.200605-587ST.CrossRefPubMed
129.
go back to reference Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, Harrell FE, Connors AF: Dying with lung cancer or chronic obstructive pulmonary Disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 2000, 48: S146-S153.CrossRefPubMed Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, Harrell FE, Connors AF: Dying with lung cancer or chronic obstructive pulmonary Disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 2000, 48: S146-S153.CrossRefPubMed
130.
go back to reference Carlucci A, Guerrieri A, Nava S: Palliative care in COPD patients: is it only an end-of-life issue?. Eur Respir Rev. 2012, 21 (126): 347-354. 10.1183/09059180.00001512.CrossRefPubMed Carlucci A, Guerrieri A, Nava S: Palliative care in COPD patients: is it only an end-of-life issue?. Eur Respir Rev. 2012, 21 (126): 347-354. 10.1183/09059180.00001512.CrossRefPubMed
131.
go back to reference Goodridge DM, Marciniuk DD, Brooks D, van Dam A, Hutchinson S, Bailey P, Baxter S, Dorasamy P, Dumont S, Hassan S, Hernandez P, Kerigan A, Rocker G, Wilson D, Young J: End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting. Can Respir J. 2009, 16 (5): e51-e53.PubMedCentralPubMed Goodridge DM, Marciniuk DD, Brooks D, van Dam A, Hutchinson S, Bailey P, Baxter S, Dorasamy P, Dumont S, Hassan S, Hernandez P, Kerigan A, Rocker G, Wilson D, Young J: End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting. Can Respir J. 2009, 16 (5): e51-e53.PubMedCentralPubMed
132.
Metadata
Title
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*
Authors
Stefano Nardini
Isabella Annesi-Maesano
Mario Del Donno
Maurizio Delucchi
Germano Bettoncelli
Vincenzo Lamberti
Carlo Patera
Mario Polverino
Antonio Russo
Carlo Santoriello
Patrizio Soverina
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2014
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/2049-6958-9-46

Other articles of this Issue 1/2014

Multidisciplinary Respiratory Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.